Skip to main content
. 2025 Jan 3;11(1):e41652. doi: 10.1016/j.heliyon.2025.e41652

Table 4.

Solubility, total phenol, density and encapsulation efficiency for microencapsulated Sargassum ilisifolium.

Treatment Code Solubility (%) Total Phenol (mg/ml) Density (g/ml) Encapsulation Efficiency (%)
M 84.0 ± 2.90c 0.04 ± 0.01c 0.03 ± 0.01f 39.76 ± 0.64g
N 30.0 ± 2.13f 0.01 ± 0.01g 0.02 ± 0.04f 13.41 ± 1.09i
O 93.33 ± 2.75b 0.03 ± 0.02g 0.05 ± 0.05f 29.42 ± 0.95h
D 93.0 ± 2.15b 0.07 ± 0.03ef 0.20 ± 0.04cd 67.81 ± 0.79f
E 67.5 ± 1.50de 0.08 ± 0.01g 0.20 ± 0.02cd 72.72 ± 1.24e
F 10.2 ± 2.73h 0.09 ± 0.02de 0.14 ± 0.01e 78.50 ± 0.80d
G 98.0 ± 2.80a 0.11 ± 0.01f 0.20 ± 0.03cd 98.66 ± 0.54a
H 66.6 ± 1.80e 0.10 ± 0.02f 0.44 ± 0.03a 87.99 ± 0.66b
I 65.0 ± 2.50e 0.11 ± 0.05b 0.16 ± 0.02de 99.26 ± 1.40a
A 20.0 ± 2.88g 0.01 ± 0.02a 0.24 ± 0.01bc 83.77 ± 0.73c
B 71.42 ± 2.08d 0.09 ± 0.02g 0.19 ± 0.03cde 79.67 ± 1.03d
C 80.0 ± 2.37c 0.11 ± 0.05d 0.28 ± 0.02b 95.27 ± 1.49b

∗ Data are reported as (mean ± standard deviation) in three replicates.

∗∗The same lowercase letters in each column row indicate no significant difference (P > 0.05) between the data based on Duncan's test.

∗∗∗(A): Maltodexterin (50 %) + WPI (50 %) - 4:1; (B): Maltodexterin (50 %) + WPI (50 %) - 8:1; (C): Maltodexterin (50 %) + WPI (50 %) - 12:1; (D): Maltodexterin (30 %) + WPI (70 %) - 4:1; (E): Maltodexterin (30 %) + WPI (70 %) - 8:1; (F): Maltodexterin (30 %) + WPI (70 %) - 12:1; (G): Maltodexterin (70 %) + WPI (30 %) - 4:1; (H): Maltodexterin (70 %) + WPI (30 %) - 8:1; (I): Maltodexterin (70 %) + WPI (30 %) - 12:1; (M): Chitosan (10 %) - 4:1; (N): Chitosan (10 %) - 8:1; (O): Chitosan (10 %) - 12:1.